Omaha, Neb. – Streck’s Research and Development Scientific Manager Dr. Chris Connelly will speak in the molecular diagnostics for infectious disease track at the Next Generation Dx Summit in Washington, D.C.

Connelly will present “New real-time PCR applications that will accelerate workflow for molecular diagnostic analysis” at 9:45 a.m. on Thursday, Aug. 20, in the Congressional Room, Capital Hilton Hotel.

The program will focus on PCR-based applications for the Philisa® Real-Time PCR System that serve to accelerate workflow for molecular diagnostic analysis. Critical assays for infectious disease testing, such as detection of antibiotic resistant bacteria and RT-PCR-based identification of viruses, will benefit from the versatility and performance of the Philisa Real-Time PCR System.

The Next Generation Dx Summit brings together more than 900 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Visit for more information about this show.

Connelly is manager of the Molecular Technology Division at Streck. His current research explores rapid PCR-based approaches to develop molecular diagnostic tests for clinical and research laboratories. He received his Ph.D. in biochemistry and molecular biology from the University of Nebraska Medical Center in 2010 and has 13 years combined R&D experience in academia and the private sector.

About Streck, Inc.
Streck is an industry leader in the development and manufacturing of products for clinical and research laboratories. The company’s pursuit of innovative solutions has produced an extensive list of patented products. Streck’s core technology is cell stabilization; product lines support the fields of hematology, immunology and molecular diagnostics. For more information, visit

What we offer

Upcoming Events >